Your browser doesn't support javascript.
loading
Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis.
Prokopidis, Konstantinos; Giannos, Panagiotis; Katsikas Triantafyllidis, Konstantinos; Kechagias, Konstantinos S; Mesinovic, Jakub; Witard, Oliver C; Scott, David.
Afiliação
  • Prokopidis K; Department of Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Giannos P; Society of Meta-research and Biomedical Innovation, London, UK.
  • Katsikas Triantafyllidis K; Society of Meta-research and Biomedical Innovation, London, UK.
  • Kechagias KS; Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, UK.
  • Mesinovic J; Society of Meta-research and Biomedical Innovation, London, UK.
  • Witard OC; Department of Nutrition & Dietetics, Musgrove Park Hospital, Taunton & Somerset NHS Foundation Trust, Taunton, UK.
  • Scott D; Society of Meta-research and Biomedical Innovation, London, UK.
J Cachexia Sarcopenia Muscle ; 13(3): 1642-1652, 2022 06.
Article em En | MEDLINE | ID: mdl-35261183
ABSTRACT

BACKGROUND:

Vitamin D supplementation is proposed as a potentially effective nutritional intervention to mitigate the risk of sarcopenia. The aim of this systematic review and meta-analysis was to investigate the impact of vitamin D supplementation monotherapy on indices of sarcopenia in community-dwelling older adults.

METHODS:

A comprehensive search of the literature was conducted in PubMed, Web of Science, Scopus, and Cochrane Library. Eligible randomized controlled trials (RCTs) compared the effect of vitamin D supplementation (as monotherapy) with placebo on indices of sarcopenia in older (>50 years) adults. Using the random effects inverse-variance model, we calculated the mean difference (MD) in handgrip strength (HGS), short physical performance battery (SPPB), timed up and go (TUG), and appendicular lean mass (ALM) between groups. We also calculated the standardized mean difference (SMD) in general muscle strength and general physical performance (composite plot of all muscle strength and physical performance outcomes, respectively) between groups.

RESULTS:

Ten RCTs were included in the meta-analysis. A significant decrease in SPPB scores was observed with vitamin D supplementation compared with placebo (MD -0.23; 95% CI -0.40 to -0.06; I2  = 0%; P = 0.007). Vitamin D supplementation conferred no effect on HGS (MD -0.07 kg; 95% CI -0.70 to 0.55; I2  = 51%, P = 0.82), TUG (MD 0.07 s; 95% CI -0.08 to 0.22; I2  = 0%, P = 0.35), ALM (MD 0.06 kg/m2 ; 95% CI -0.32 to 0.44; I2  = 73%, P = 0.77), general muscle strength (SMD -0.01; 95% CI -0.17 to 0.15; I2  = 42%, P = 0.90), or general physical performance (SMD -0.02; 95% CI -0.23 to 0.18; I2  = 71%, P = 0.83).

CONCLUSIONS:

Vitamin D supplementation did not improve any sarcopenia indices in community-dwelling older adults and may compromise some aspects of physical performance. Future studies are warranted to investigate the impact of vitamin D supplementation on individual indices of SPPB, including mobility and balance, in older adults.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article